Gm1614 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the Gm1614 gene product, a gene identified in the mouse genome. Although Gm1614 is not widely characterized in the literature, like many genes of its kind, it likely plays a role in fundamental cellular processes such as gene regulation, protein synthesis, or intracellular signaling. Inhibitors targeting Gm1614 function by interfering with its ability to participate in these processes, either by blocking its interaction with other proteins or preventing its enzymatic or regulatory functions. These inhibitors effectively disrupt the gene's role within cellular pathways, allowing researchers to explore the biological consequences of Gm1614 inhibition.
Research using Gm1614 inhibitors provides critical insights into the gene's role in maintaining cellular function and homeostasis. By blocking Gm1614, scientists can observe how its inhibition affects various cellular mechanisms, such as transcriptional control, protein modification, or metabolic regulation. These inhibitors help reveal how Gm1614 contributes to the broader networks of molecular interactions that sustain life at the cellular level. Additionally, studying the effects of Gm1614 inhibition enables researchers to map out its specific contributions to cellular organization and its interaction with other genes and proteins. Through such research, Gm1614 inhibitors are valuable tools for understanding the complex regulatory systems within cells, highlighting the gene's importance in maintaining the balance of cellular processes and its potential role in adapting to environmental or intracellular changes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits phosphoinositide 3-kinases (PI3K), which can alter signaling pathways where PROB1 may participate. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that can disrupt downstream signaling pathways potentially involving PROB1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, affecting the MAPK/ERK pathway which might intersect with PROB1's functional pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, impacting stress response pathways where PROB1 could be implicated. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, modifying the JNK signaling pathway that PROB1 may be part of. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
PKC inhibitor that can alter cell signaling cascades, potentially influencing PROB1 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK kinase, potentially affecting cytoskeletal organization and signaling related to PROB1. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor that can affect multiple signaling pathways, possibly including those involving PROB1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which could impact the ERK pathway and indirectly affect PROB1 activities. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, which may alter cell growth and proliferation pathways where PROB1 is involved. | ||||||